Brazilian Healthcare Embraces Dapagliflozin for Heart Failure Patients

Brazil's public health system is set to incorporate dapagliflozin into standard treatment protocols for patients with heart failure with reduced ejection fraction (HFrEF). This decision stems from new research...

Upcoming Meetings

Pharmacoeconomics

Global Market Access
Latest

Brazilian Healthcare Embraces Dapagliflozin for Heart Failure Patients

Brazil's public health system is set to incorporate dapagliflozin into standard treatment protocols for patients with heart failure with reduced ejection fraction (HFrEF). This...

Study Reveals Key Insights into Uterine Health Among Saudi Women

A recent cohort study conducted at Princess Nourah bint Abdulrahman University has shed light on the variations in uterine measurements and endometrial thickness throughout...

Actis Total Hip System Demonstrates Strong Five-Year Performance

Patients receiving the Actis Total Hip System have shown promising results over a five-year period, according to a recent study. The Actis stem, known...

New Modeling Technique Enhances Understanding of Vein Compression Risks

Advancements in Computational Fluid Dynamics (CFD) have paved the way for more accurate assessments of Iliac Vein Compression Syndrome (IVCS), a significant contributor to...

Policy Leaders Chart Path for EU Health Technology Assessment Rollout

In a decisive meeting held in Rome in May 2024, leading experts in Health Technology Assessment (HTA) within the European Union convened to address...

HEOR

MedTech